After MAECs were lysed on ice with protein lysis buffer (1% Nonidet P-40, 150 mM NaCl, 20 mM Tris-HCl, pH 8.0, with the addition of a protease inhibitor cocktail), they were centrifuged at 12 000× g and 4°C for 20 min. Orai1–3 or VE-cadherin proteins were immunoprecipitated by incubating 800 μg of extracted protein with 5 µg of anti-Orai1–3 antibodies (ProteinTech Group, Chicago, Illinois, USA) or anti-VE-cadherin antibody (Affinity Biosciences, Ohio, USA), respectively, on a rocking platform overnight at 4℃. Protein A agarose was then added and incubated for an additional 3 hours at 4℃. The immunoprecipitates were washed with cell lysis solution, and cell lysates (100 µL) and loading buffer (25 µL) were added. Next, the sample was boiled at 100°C for 10 min. The resulting obtained supernatant was used for protein electrophoresis. For the immunoblots, all of the samples were fractionated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis using 15% agarose gels, transferred to polyvinylidene fluoride membranes, and probed with the indicated primary antibodies at a dilution of 1:200 in a phosphate-buffered saline (PBS; in mM: 137 NaCl, 2.7 KCl, 10 Na2HPO4, 1.8 KH2PO4, pH 7.4) containing 0.1% Tween-20 and 5% non-fat dry milk. Immunodetection was accomplished using horseradish peroxidase (HRP)-conjugated secondary antibody (1:5000, Affinity Biosciences) followed by an enhanced chemiluminescence plus detection system (Peiqing, Shanghai, China).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.